Spots Global Cancer Trial Database for urinary tract cancer
Every month we try and update this database with for urinary tract cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer | NCT02006667 | Urinary Tract C... | trastuzumab gemcitabine cisplatin | 18 Years - | Hoffmann-La Roche | |
| Multimodal Spectroscopy to Detect Urothelial Cancer in Urine | NCT04718948 | Urothelial Carc... Urinary Bladder... Urinary Tract C... | Urinary Multimo... Urine Cytology Surgery | 18 Years - | University of Florence | |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S | NCT04430842 | Astrocytoma Brain Cancer Brain Metastase... Bladder Cancer Breast Cancer Cervical Cancer Cholangiocarcin... Colorectal Canc... Esophagus Cance... Gastric Cancer Head and Neck C... Kidney Cancer Liver Cancer Lung Cancer Melanoma Ovarian Cancer Pancreatic Canc... Pleural Mesothe... Prostate Cancer Sarcoma Tongue Cancer Thymic Carcinom... Urinary Tract C... | QBS10072S | 18 Years - | Quadriga Biosciences, Inc. | |
| Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). | NCT05038657 | Squamous Cell C... Urinary Tract C... | Atezolizumab | 18 Years - | University Hospital Southampton NHS Foundation Trust | |
| A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract | NCT02928406 | Urinary Tract C... | Atezolizumab | 18 Years - | Hoffmann-La Roche | |
| Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). | NCT05038657 | Squamous Cell C... Urinary Tract C... | Atezolizumab | 18 Years - | University Hospital Southampton NHS Foundation Trust | |
| Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue | NCT02379429 | Bladder Cancer Urinary Tract C... Urothelial Canc... Healthy Volunte... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract | NCT02928406 | Urinary Tract C... | Atezolizumab | 18 Years - | Hoffmann-La Roche | |
| CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma | NCT03013920 | Urinary Tract C... Urothelial Carc... Ureter Cancer | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | ||
| A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer | NCT02006667 | Urinary Tract C... | trastuzumab gemcitabine cisplatin | 18 Years - | Hoffmann-La Roche | |
| An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma | NCT02783300 | Neoplasms | GSK3326595 Pembrolizumab | 18 Years - | GlaxoSmithKline | |
| Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue | NCT02379429 | Bladder Cancer Urinary Tract C... Urothelial Canc... Healthy Volunte... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| A Study of LOXO-435 in Participants With Cancer With a Change in a Gene Called FGFR3 | NCT05614739 | Urinary Bladder... Neoplasm Metast... Ureteral Neopla... | LOXO-435 Pembrolizumab | 18 Years - | Eli Lilly and Company | |
| Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study | NCT03410641 | Cancer Gastrointestina... Lung Cancer Urinary Tract C... Prostate Cancer | Diet and antism... | 40 Years - 49 Years | Oslo University Hospital | |
| A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer | NCT02013765 | Urinary Tract C... | trastuzumab | 18 Years - | Hoffmann-La Roche | |
| A Study of LOXO-435 in Participants With Cancer With a Change in a Gene Called FGFR3 | NCT05614739 | Urinary Bladder... Neoplasm Metast... Ureteral Neopla... | LOXO-435 Pembrolizumab | 18 Years - | Eli Lilly and Company |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
